The specificities of protein kinase inhibitors: An update

Biochemical Journal

Volumn 371, Issue 1, 2003, Pages 199-204

  Bain, Jenny ^a   McLauchlan, Hilary ^a   Elliott, Matthew ^a   Cohen, Philip ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Kenpaullone; Protein kinase inhibitors; Protein phosphorylation; Roscovitine; SP 600125; Src

Indexed keywords

BIOCHEMISTRY; PROTEINS; SUBSTRATES;

PROTEIN KINASE INHIBITORS;

ENZYME INHIBITION;

1 (5 CHLORO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; 1 (5 IODO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; 2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; ALSTERPAULLONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIN DEPENDENT KINASE; EPIGALLOCATECHIN GALLATE; GLYCOGEN SYNTHASE KINASE 3; INDIRUBIN 3' MONOXIME; KENPAULLONE; KT 5823; LITHIUM CHLORIDE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PURVALANOL; PYRAZOLOPYRIMIDINE DERIVATIVE; ROSCOVITINE; UNCLASSIFIED DRUG; 4 AMINO 5 (4 METHYLPHENYL) 7 (TERT BUTYL)PYRAZOLO(3,4 D)PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4-AMINO-5-(4-METHYLPHENYL)-7-(TERT-BUTYL)PYRAZOLO(3,4-D)PYRIMIDINE; ALKALOID; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; AZEPINE DERIVATIVE; BENZAZEPINE DERIVATIVE; CARBAZOLE DERIVATIVE; CATECHIN; DRUG DERIVATIVE; ENZYME INHIBITOR; INDIRUBIN-3'-MONOXIME; INDOLE DERIVATIVE; KINETIN; MITOGEN ACTIVATED PROTEIN KINASE; NAPHTHALENE DERIVATIVE; OLOMOUCINE; OXIME; PROTEIN TYROSINE KINASE; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; IC 50; PHYSIOLOGY; PRIORITY JOURNAL; DRUG ANTAGONISM; ENZYME SPECIFICITY; SIGNAL TRANSDUCTION;

ALKALOIDS; ANTHRACENES; AZEPINES; BENZAZEPINES; CARBAZOLES; CATECHIN; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; INDOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETIN; MITOGEN-ACTIVATED PROTEIN KINASES; NAPHTHALENES; OXIMES; PROTEIN KINASE INHIBITORS; PURINES; PYRAZOLES; PYRIMIDINES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SUBSTRATE SPECIFICITY;

EID: 0037392942     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20021535     Document Type: Article

References (40)

1. Cohen, P. (2002) Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Disc. 1, 309-315
2. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J. and Saltiel, A. R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U.S.A. 92, 7686-7689
3. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F. et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632
4. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. and Saltiel, A. R. (1995) PD 98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494
5. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R. and Lee, J. C. (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233
6. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105
7. Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B. and Schreiber, S. L. (1995) Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature (London) 377, 441-446
8. Eyers, P. A., van den Ijessel, P., Quinlan, R. A., Goedert, M. and Cohen, P. (1999) Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580. FEBS Lett. 451, 191-196
9. Vesely, J., Havlicek, L., Strnad, M., Blow, J. J., Donella-Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S. et al. (1994) Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224, 771-786
10. Meijer, L., Borgne, A., Mulner, O., Chong, J. P., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J. G. and Moulinoux, J. P. (1997) Biochemical and cellular effects of Roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527-536
11. Gray, N. S., Wodicka, L., Thunnissen, A. W. H., Norman, T. C., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., LeClerc, S., Meijer, L. et al. (1998) Exploiting chemical libraries, structure and genomics in the search for kinase inhibitors. Science 281, 533-538
12. Knockaert, M., Lenormand, P., Gray, N., Schultz, P., Pouyssegur, J. and Meijer, L. (2002) p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol. Oncogene 21, 6413-6424
13. Hoessel, R., Leclerc, S., Endicott, J. A., Nobel, M. E. M., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D. et al. (1999) Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent protein kinases. Nat. Cell Biol. 1, 60-67
14. LeClerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y.-Z., Mandelkow, E.-M. et al. (2001) Indirubins inhibit glycogen synthase kinase-3 β and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J. Biol. Chem. 276, 251-260
15. Schultz, C., Link, A., Leost, M., Zaharevitz, D. W., Gussio, R., Sausville, E. A., Meijer, L. and Kunick, C. (1999) Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity. J. Med. Chem. 42, 2909-2919
16. Leost, M., Schultz, C., Link, A., Wu, Y.-Z., Biernat, J., Mandelkow, E-M., Bibb, J. A., Snyder, G. L., Greengard, P., Zaharevitz, D. W. et al. (2000) Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25. Eur. J. Biochem. 267, 5983-5994
17. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A. and Connelly, P. A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent cell activation. J. Biol. Chem. 271, 695-701
18. Liu, Y., Bishop, A., Witucki, L., Kraybill, B., Shimuza, E., Tsien, J., Ubersax, J., Blethrow, J., Morgan, D. O. and Shokat, K.M (1999) Structural basis for selective inhibition of Src family kinases by PP1. Chem. Biol. 6, 671-678
19. Blake, R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M., Sun, L. and Courtneidge, S. A. (2000) SU 6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20, 9018-9027
20. Bennett, B. L., Saskai, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y. et al. (2001) SP 600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 98, 13681-13686
21. Firestein, B. L. and Bredt, D. S. (1998) Regulation of sensory neuron precursor proliferation by cyclic GMP-dependent protein kinase. J. Neurochem. 71, 1846-1853
22. Chiche, J.-D., Schlutsmeyer, S. M., Bloch, D. B., de la Monte, S. M., Roberts, J., Filippov, G., Janssens, S. P., Rosenzweig, A. and Bloch, K. D. (1998) Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J. Biol. Chem. 273, 34263-34271
23. Elferink, J. G. and De Koster, B. M. (1998) The involvement of protein kinase G in stimulation of neutrophil migration by endothelins. Eur. J. Pharmacol. 350, 285-291
24. Burkhardt, M., Glazova, M., Gambaryan, S., Vollkommer, T., Butt, E., Bader, B., Heermeier, K., Lincoln, T. M., Walter, U. and Palmetshofer, A. (2000) KT 5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J. Biol. Chem. 275, 33536-33541
25. Saitoh, M., Ishikawa, T., Matsushima, S., Naka, M. and Hidaka, H. (1987) Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J. Biol. Chem. 262, 7796-7801
26. Klein, P. S. and Melton, D. A. A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U.S.A. 93, 8455-8459
27. Cheng, K., Creacy, S. and Larner, J. (1983) "Insulin-like" effects of lithium ion on isolated rat adipocytes. II Specific activation of glycogen synthase. Mol. Cell. Biochem. 56, 183-189
28. Stambolic, V., Ruel, L. and Woodgett, J. R. (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6, 1664-1668
29. Young, R. C. and Downes, C. P. (1990) Inositol phospholipid-dependent cellular signalling: opportunities for drug discovery. Drug Des. Delivery 6, 1-13
30. Nada, S., Okada, M., MacAuley, A., Cooper, J. A. and Nakagawa, H. (1991) Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature (London) 351, 69-72
31. Gum, R. J., McLaughlin, M. M., Kumar, S., Wang, Z., Bower, M. J., Lee, J. C., Adama, J. L., Livi, G. P., Goldsmith, E. J. and Young, P. R. (1998) Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J. Biol. Chem. 273, 15605-15610
32. Eyers, P. A., Craxton, M., Morrice, N., Cohen, P. and Goedert, M. (1998) Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino acid substitution. Chem. Biol. 5, 321-328
33. Han, Z., Boyle, D. L., Chang, L., Bennet, B., Karin, M., Yang, L., Manning, A. M. and Firestein, G. S. (2001) c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108, 181-183
34. Shin, M., Yan, C. and Boyd, D. (2002) An inhibitor of c-jun aminoterminal kinase (SP 600125) represses c-Jun activation, DNA-binding and PMA-inducible 92 kDa type IV collagenase expression. Biochim. Biophys. Acta 1589, 311-316
35. Schnabl, B., Bradham, C. A., Bennett, B. L., Manning, A. M., Stefanovic, B. and Brenner, D. A. (2001) TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepatology 34, 953-963
36. + exchange in Xenopus oocytes. Am. J. Physiol. 281, 1978-1990
37. Yang, C. S. and Wang, Z. Y. (1993) Tea and cancer. J. Natl. Cancer Inst. 85, 1038-1049
38. Katiyar, S. K., Afaq, F., Azizuddin, K. and Mukhtar, H. (2001) Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol. Appl. Pharmacol. 176, 110-117
39. Ahn, H. Y., Hadizadeh, K. R., Seul, C., Yun, Y. P., Vetter, H. and Sachinidis, A. (1999) Epigallocatechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol. Biol. Cell 10, 1093-1104
40. Llang, Y. C., Lin-Shiau, S. Y., Chen, C. F. and Lin, J. K. (1999) Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J. Cell. Biochem. 75, 1-12